Sha HH - Search Results

1

Relationship between plasma circulating cell-free DNA concentration and treatment outcomes including prognosis in patients with advanced non-small cell lung cancer.

Peng WW, Liu Y, Sha HH, Wen SD, Fang Y, Zhou GR. Peng WW, et al. Among authors: sha hh. BMC Pulm Med. 2023 Sep 14;23(1):348. doi: 10.1186/s12890-023-02586-2. BMC Pulm Med. 2023. PMID: 37710221 Free PMC article.

2

Role and mechanism of miR-187 in human cancer.

Peng W, Sha H, Sun X, Zou R, Zhu Y, Zhou G, Feng J. Peng W, et al. Am J Transl Res. 2020 Sep 15;12(9):4873-4884. eCollection 2020. Am J Transl Res. 2020. PMID: 33042395 Free PMC article. Review.

3

MicroRNA-381 in human cancer: Its involvement in tumour biology and clinical applications potential.

Sha H, Gan Y, Xu F, Zhu Y, Zou R, Peng W, Wu Z, Ma R, Wu J, Feng J. Sha H, et al. J Cell Mol Med. 2022 Feb;26(4):977-989. doi: 10.1111/jcmm.17161. Epub 2022 Jan 11. J Cell Mol Med. 2022. PMID: 35014178 Free PMC article. Review.

4

To be, or not to be: the dilemma of immunotherapy for non-small cell lung cancer harboring various driver mutations.

Cai R, Zhu H, Liu Y, Sha H, Peng W, Yin R, Zhou G, Fang Y. Cai R, et al. J Cancer Res Clin Oncol. 2023 Sep;149(12):10027-10040. doi: 10.1007/s00432-023-04919-4. Epub 2023 Jun 1. J Cancer Res Clin Oncol. 2023. PMID: 37261523 Free PMC article. Review.

5

A retrospective real-world study: the efficacy of immune-related combination therapies in advanced non-small cell lung cancer after resistance to EGFR-TKIs.

Cai R, Liu Y, Yu M, Sha H, Guo M, Chen Y, Ye J, Zhou G, Fang Y, Shen B. Cai R, et al. Cancer Immunol Immunother. 2023 Dec;72(12):4355-4365. doi: 10.1007/s00262-023-03570-9. Epub 2023 Oct 31. Cancer Immunol Immunother. 2023. PMID: 37907645 Free PMC article.

6

A case report: A new promising treatment for pulmonary sarcomatoid carcinoma - Tislelizumab and Anlotinib combined with local radiotherapy.

Cai R, Liu Y, Sha H, Yu J, Fang Y, Zhou G, Shen B. Cai R, et al. Heliyon. 2023 Nov 2;9(11):e21902. doi: 10.1016/j.heliyon.2023.e21902. eCollection 2023 Nov. Heliyon. 2023. PMID: 38027958 Free PMC article.

7

Efficacy of rechallenge after first-line immunotherapy for advanced gastric cancer: A retrospective real-world study.

Guo M, Zhao W, Chen Y, Zou D, Peng W, Sha H, Zhou G, Fang Y, Shen B. Guo M, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2423479. doi: 10.1080/21645515.2024.2423479. Epub 2024 Nov 4. Hum Vaccin Immunother. 2024. PMID: 39494935 Free PMC article.

8

Liver X receptors agonist GW3965 re-sensitizes gefitinib-resistant human non-small cell lung cancer cell to gefitinib treatment by inhibiting NF-κB in vitro.

Hu Y, Zang J, Cao H, Wu Y, Yan D, Qin X, Zhou L, Fan F, Ni J, Xu X, Sha H, Liu S, Yu S, Wang Z, Ma R, Wu J, Feng J. Hu Y, et al. Oncotarget. 2017 Feb 28;8(9):15802-15814. doi: 10.18632/oncotarget.15007. Oncotarget. 2017. PMID: 28178657 Free PMC article.

9

Genome-wide profiling of micro-RNA expression in gefitinib-resistant human lung adenocarcinoma using microarray for the identification of miR-149-5p modulation.

Hu Y, Qin X, Yan D, Cao H, Zhou L, Fan F, Zang J, Ni J, Xu X, Sha H, Liu S, Yu S, Wu J, Ma R, Feng J. Hu Y, et al. Tumour Biol. 2017 Mar;39(3):1010428317691659. doi: 10.1177/1010428317691659. Tumour Biol. 2017. PMID: 28345454 Free article.

10

Cytokine-induced killer cells as a feasible adoptive immunotherapy for the treatment of lung cancer.

Chen D, Sha H, Hu T, Dong S, Zhang J, Liu S, Cao H, Ma R, Wu Y, Jing C, Wang Z, Wu J, Feng J. Chen D, et al. Cell Death Dis. 2018 Mar 6;9(3):366. doi: 10.1038/s41419-018-0404-5. Cell Death Dis. 2018. PMID: 29511158 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters